AKC Canine Health Foundation and
Golden Retriever Foundation
Cancer Research Collaborative Project
Funded In Part by the GRF SHINE ON Challenge
click here to flier with information about The Shine On Project
Here are the Winners!
Join The GRF in the
Shine On Challenge
As We Eagerly Support
A Novel Approach for Prevention of Canine Hemangiosarcoma:
The MEDTECH Study (Monitoring for Early Detection and Targeted Elimination of Canine Hemangiosarcoma)
Project Description by Principal Investigator: Jaime F. Modiano, VMD, PhD
Project Duration: 36 months
(We are thrilled to announce that the project has been approved by the Canine Health Foundation, and will be starting in January 2016!)
The Problem: Hemangiosarcoma is the cause of death for one out of every five Golden Retrievers in the United States. Portuguese Water Dogs and Boxers also have an especially high risk for this disease. One feature that makes hemangiosarcoma incurable is the fact that it is almost always detected at a very advanced stage when it is resistant to conventional therapies. This insidious cancer almost always grows out of sight without causing pain or obvious symptoms, so it is diagnosed late in the course of disease or after death.
The Opportunity: Solving the cancer problem is a long-term challenge. However, we believe we have reached a point where we can diagnose hemangiosarcoma in the early stages and treat this disease before it reaches the clinical crisis point. Our goal is to continue development of two technologies that will allow us to achieve this.
Approach: We will recruit cases with a confirmed or presumed diagnosis of hemangiosarcoma and dogs with no evidence of hemangiosarcoma of any age and any breed, as this will accelerate the process of validation.
Summary: The anticipated result will be preliminary tests for detection of circulating hemangiosarcoma cancer stem cells that will be in a “beta”- ready format, along with a safe and reliable treatment option for prevention of disease.
DREAM WITH US!